| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHECK CAP LTD | 53,763 | 38,000 | 0.03% | ||
| 2 | CEL SCI CORP | 127,482 | 47,000 | 0.04% | ||
| 3 | ANTARES PHARMA INC | 45,000 | 54,000 | 0.05% | ||
| 4 | ENTEROMEDICS INC | 500,000 | 65,000 | 0.06% | ||
| 5 | GALMED PHARMACEUTICALS LTD | 11,988 | 91,000 | 0.08% | SH | |
| 6 | Nivalis Therapeutics Inc | 15,000 | 116,000 | 0.10% | ||
| 7 | AKARI THERAPEUTICS PLC | 8,341 | 121,000 | 0.11% | ||
| 8 | Sierra Oncology, Inc. | 10,000 | 150,000 | 0.13% | ||
| 9 | TREVENA INC | 14,800 | 155,000 | 0.14% | SH | |
| 10 | GENVEC INC | 95,800 | 176,000 | 0.16% | SH | |
| 11 | VENAXIS INC | 594,800 | 181,000 | 0.16% | SH | |
| 12 | CHECK CAP LTD | 109,133 | 206,000 | 0.18% | ||
| 13 | CARDICA INC | 1,402,762 | 216,000 | 0.19% | SH | |
| 14 | CATALYST | 70,903 | 222,000 | 0.20% | ||
| 15 | TENAX THERAPEUTICS INC | 79,509 | 261,000 | 0.23% | ||
| 16 | NEMUS BIOSCIENCE INC | 625,000 | 341,000 | 0.30% | ||
| 17 | BLUEBIRD BIO INC COM | 6,000 | 385,000 | 0.34% | SH | |
| 18 | CYTOKINETICS INC | 40,000 | 418,000 | 0.37% | ||
| 19 | TANDEM DIABETES CARE INC COM | 36,551 | 432,000 | 0.39% | ||
| 20 | COGENTIX MED INC | 351,781 | 454,000 | 0.40% | ||
| 21 | FOAMIX PHARMACEUTICALS LTD | 60,770 | 493,000 | 0.44% | ||
| 22 | VTV THERAPEUTICS INC | 73,000 | 497,000 | 0.44% | ||
| 23 | CYNAPSUS THERAPEUTICS INC | 33,995 | 526,000 | 0.47% | SH | |
| 24 | TARGACEPT INC | 530,821 | 531,000 | 0.47% | PRN | |
| 25 | ENDOLOGIX INC | 500,000 | 545,000 | 0.49% | PRN | |
| 26 | IRONWOOD PHARMA | 600,000 | 563,000 | 0.50% | PRN | |
| 27 | Exactech Inc | 31,636 | 574,000 | 0.51% | SH | |
| 28 | UNIQURE NV | 35,000 | 579,000 | 0.52% | SH | |
| 29 | ADAPTIMMUNE THERAPEUTICS PLC | 48,100 | 580,000 | 0.52% | ||
| 30 | ALDER BIOPHARMACEUTICALS INC | 18,000 | 595,000 | 0.53% | ||
| 31 | ABEONA THERAPEUTICS INC | 181,818 | 611,000 | 0.54% | ||
| 32 | INTEC PHARMA LTD JERUSALEM | 119,296 | 639,000 | 0.57% | ||
| 33 | LIPOCINE INC NEW | 50,000 | 647,000 | 0.58% | ||
| 34 | SYNERON MEDICAL LTD | 85,947 | 663,000 | 0.59% | SH | |
| 35 | CYNAPSUS THERAPEUTICS INC | 46,629 | 722,000 | 0.64% | ||
| 36 | Arena Pharmaceuticals, Inc | 381,600 | 725,000 | 0.65% | ||
| 37 | MACROGENICS INC | 24,000 | 743,000 | 0.66% | ||
| 38 | REGULUS THERAPEUTICS INC COM | 90,000 | 785,000 | 0.70% | ||
| 39 | XENON PHARMACEUTICALS INC | 97,730 | 786,000 | 0.70% | ||
| 40 | CAREDX INC | 136,047 | 871,000 | 0.78% | SH | |
| 41 | NEOS THERAPEUTICS INC COM | 63,400 | 908,000 | 0.81% | ||
| 42 | JOHNSON & JOHNSON | 9,400 | 966,000 | 0.86% | SH | |
| 43 | SCYNEXIS INC | 156,904 | 974,000 | 0.87% | SH | |
| 44 | Ascendis Pharma | 53,241 | 975,000 | 0.87% | ||
| 45 | Stereotaxis Inc | 1,372,862 | 1,021,000 | 0.91% | SH | |
| 46 | ZOGENIX INC | 69,400 | 1,023,000 | 0.91% | ||
| 47 | ESSA Pharma | 228,500 | 1,045,000 | 0.93% | ||
| 48 | NUVASIVE INC | 760,000 | 1,045,000 | 0.93% | PRN | |
| 49 | SPECTRANETICS CORP | 79,812 | 1,202,000 | 1.07% | SH | |
| 50 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,297,000 | 1.16% | SH |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000022, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
